SCHEMBL8375005

SCHEMBL8375005

COc1cccc(-c2cc(OCCNC(=O)OC(C)(C)C)no2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.59
NPC1 O15118 7/20 0.59
SMN1; SMN2 Q16637 5/20 0.59
TP53 P04637 5/20 0.59
HPGD P15428 4/20 0.59
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 2/20 0.59
ALDH1A1 P00352 5/20 0.50
MAPT P10636 6/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
TSHR P16473 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPK1 P28482 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
NFKB1 P19838 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8380141 0.89 NPC1 (0.51) RAB9ANPC1SMN1; SMN2TP53HPGD
SCHEMBL8378941 0.87 GABRA5 (0.46) RAB9ASMN1; SMN2KMT2AMAPK1
SCHEMBL8380096 0.87 TP53 (0.57) RAB9ANPC1SMN1; SMN2TP53HPGD
SCHEMBL8375557 0.85 BCHE (0.47)
SCHEMBL8378917 0.84 BCHE (0.49)
SCHEMBL8380047 0.83 CYP3A4 (0.45) RAB9ANPC1SMN1; SMN2TP53HPGD
SCHEMBL8375551 0.82 HDAC1 (0.44) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL8379534 0.82 TP53 (0.47) RAB9ANPC1TP53HPGDALDH1A1
SCHEMBL8375017 0.82 NPC1 (0.50) RAB9ANPC1TP53MAPTKMT2A
SCHEMBL8375763 0.81 IDO1 (0.44) SMN1; SMN2TP53CYP1A2CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed